Style | Citing Format |
---|---|
MLA | Cheraghi Z, Ayubi E, Doostiirani A. "Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: Methodologic Issues to Avoid Misinterpretation in the Meta-Analysis." Journal of Clinical Oncology, vol. 35, no. 8, 2017, pp. 923-. |
APA | Cheraghi Z, Ayubi E, Doostiirani A (2017). Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: Methodologic Issues to Avoid Misinterpretation in the Meta-Analysis. Journal of Clinical Oncology, 35(8), 923-. |
Chicago | Cheraghi Z, Ayubi E, Doostiirani A. "Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: Methodologic Issues to Avoid Misinterpretation in the Meta-Analysis." Journal of Clinical Oncology 35, no. 8 (2017): 923-. |
Harvard | Cheraghi Z, Ayubi E, Doostiirani A (2017) 'Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: Methodologic Issues to Avoid Misinterpretation in the Meta-Analysis', Journal of Clinical Oncology, 35(8), pp. 923-. |
Vancouver | Cheraghi Z, Ayubi E, Doostiirani A. Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: Methodologic Issues to Avoid Misinterpretation in the Meta-Analysis. Journal of Clinical Oncology. 2017;35(8):923-. |
BibTex | @article{ author = {Cheraghi Z and Ayubi E and Doostiirani A}, title = {Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: Methodologic Issues to Avoid Misinterpretation in the Meta-Analysis}, journal = {Journal of Clinical Oncology}, volume = {35}, number = {8}, pages = {923-}, year = {2017} } |
RIS | TY - JOUR AU - Cheraghi Z AU - Ayubi E AU - Doostiirani A TI - Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: Methodologic Issues to Avoid Misinterpretation in the Meta-Analysis JO - Journal of Clinical Oncology VL - 35 IS - 8 SP - 923 EP - PY - 2017 ER - |